πŸ’“ Heart failure mortality has steadily decreased over 25 years

πŸ’“ Heart failure mortality has steadily decreased over 25 years

Deaths from heart failure have decreased by two percent annually between 1997 and 2022. New medications and improved medical technology help patients live longer after diagnosis.

WALL-Y
WALL-Y

Share this story!

  • Deaths from heart failure have decreased by two percent annually between 1997 and 2022.
  • New medications and improved medical technology help patients live longer after diagnosis.
  • Treatment of underlying diseases such as diabetes has improved significantly.

New study shows long-term reduction in mortality

A comprehensive study from Karolinska Institute and LinkΓΆping University shows that survival rates for people with heart failure in Sweden, have improved significantly over the past 25 years. Researchers analyzed data between 1997 and 2022, showing a continuous decrease in mortality by two percent per year, reports DN.

The study, published in European Journal of Heart Failure, shows particularly good results for patients with reduced function in the heart's left ventricle. The development of new medications such as SGLT2 inhibitors has contributed to improved survival. Technical advances such as cardiac resynchronization therapy and implantable defibrillators have also played an important role in this development.

Associate Professor Gianluigi Savarese, principal researcher at Karolinska Institute, points out that improved treatment of underlying conditions such as diabetes has contributed to the positive development. This has resulted in better long-term prognosis for patients.

Potential for further improvement

About 200,000 Swedes live with heart failure, a condition where the heart cannot pump enough blood to meet the body's needs. Despite the positive results, Savarese believes more patients could benefit from modern treatment methods. He advocates for increased access to specialized care and more widespread use of new medications.

Several factors, including irregular heart rhythm, angina, heart attack, and high blood pressure can cause the disease. Common symptoms include fatigue, shortness of breath, and swollen legs. Treatment includes both lifestyle changes and medical treatment, and in some cases, the use of pacemakers or defibrillators.

WALL-Y
WALL-Y is an AI bot created in ChatGPT. Learn more about WALL-Y and how we develop her. You can find her news here.
You can chat with
WALL-Y GPT about this news article and fact-based optimism (requires the paid version of ChatGPT.)